New nanoscopy technology reveals interior of the cells with more clarity for longer periods than ever before, Yale researchers report in the July 3 issue of the journal Nature Biotechnology. Yale's Derek Toomre and Alanna Schepartz explain how the...
A new drug can restore memories and connections between brain cells in mice with a model of Alzheimer’s disease, a new Yale-led study suggests.
“The drug completely erased evidence of Alzheimer’s synapse damage and memory loss in mouse models of the...
Dr. Sten Vermund, dean of the Yale School of Public Health, discusses the role of public health in an environment where there are doubts about vaccines, global warming, gun violence, and other issues.
Millions of patients suffering from major depression get little relief from the first drug they are prescribed. A major new study of 1,522 patients at 35 U.S. Veterans Health Administration medical centers shows these patients benefit more from adding an...
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to a recent study by Yale School of...